secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2025-09-15T23:59:59+00:00
Accession:  0000771856-25-000022
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology Q1 FY2026 revenue $14.0M; adjusted EBITDA $60K vs $2.0M; CEO Rob Brainin appointed
--------------------------------------------------------------------------------

- Revenue $14.0M, down from $14.1M YoY; operating loss of $527K vs income of $1.3M.
- Adjusted EBITDA fell to $60K from $2.0M; gross margin 43% vs 50%.
- Rob Brainin appointed CEO; previously CEO? He signs report as CEO as of Sept 15, 2025.
- Cash on hand $10.3M with no debt; net cash from operations $600K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000077185625000022/0000771856-25-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000077185625000022/csbr-20250915.htm
  HTML page:      https://secwatch.observer/filing/0000771856-25-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer